Literature DB >> 1694225

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

M J Blackman1, H G Heidrich, S Donachie, J S McBride, A A Holder.   

Abstract

A complex of polypeptides derived from a precursor is present on the surface of the malaria merozoite. During erythrocyte invasion only a small fragment from this complex is retained on the parasite surface and carried into the newly infected red cell. Antibodies to this fragment will interrupt invasion.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1694225      PMCID： PMC2188181          DOI： 10.1084/jem.172.1.379

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  16 in total

Review 1.  The precursor to major merozoite surface antigens: structure and role in immunity.

Authors:  A A Holder
Journal:  Prog Allergy       Date:  1988

2.  A 46,000 dalton Plasmodium falciparum merozoite surface glycoprotein not related to the 185,000-195,000 dalton schizont precursor molecule: isolation and characterization.

Authors:  A Miettinen-Baumann; W Strych; J McBride; H G Heidrich
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

3.  A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.

Authors:  J M Burns; W R Majarian; J F Young; T M Daly; C A Long
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

4.  Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

Authors:  W A Siddiqui; L Q Tam; K J Kramer; G S Hui; S E Case; K M Yamaga; S P Chang; E B Chan; S C Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion.

Authors:  N Epstein; L H Miller; D C Kaushel; I J Udeinya; J Rener; R J Howard; R Asofsky; M Aikawa; R L Hess
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

6.  Monoclonal antibodies that protect in vivo against Plasmodium chabaudi recognize a 250,000-dalton parasite polypeptide.

Authors:  D B Boyle; C I Newbold; C C Smith; K N Brown
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Sialic acid-dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200, to human erythrocytes.

Authors:  M E Perkins; L J Rocco
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

8.  Acylation of a Plasmodium falciparum merozoite surface antigen via sn-1,2-diacyl glycerol.

Authors:  K Haldar; M A Ferguson; G A Cross
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

9.  Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies.

Authors:  R Hall; J McBride; G Morgan; A Tait; J W Zolg; D Walliker; J Scaife
Journal:  Mol Biochem Parasitol       Date:  1983-03       Impact factor: 1.759

10.  Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody.

Authors:  A A Holder; R R Freeman
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307
View more
  210 in total

1.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.

Authors:  L Wang; C G Black; V M Marshall; R L Coppel
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.

Authors:  Alan L Y Pang; Caryn N Hashimoto; Leslie Q Tam; Z Q Meng; George S N Hui; Walter K K Ho
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Small variant STEVOR antigen is uniquely located within Maurer's clefts in Plasmodium falciparum-infected red blood cells.

Authors:  M Kaviratne; S M Khan; W Jarra; P R Preiser
Journal:  Eukaryot Cell       Date:  2002-12

5.  Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus.

Authors:  Chaturong Putaporntip; Somchai Jongwutiwes; Naoko Sakihama; Marcelo U Ferreira; Weon-Gyu Kho; Akira Kaneko; Hiroji Kanbara; Tetsuya Hattori; Kazuyuki Tanabe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-04       Impact factor: 11.205

6.  Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.

Authors:  T M Daly; C A Long
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

7.  Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.

Authors:  G S Hui; A Hashimoto; S P Chang
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.

Authors:  N Ahlborg; D Haddad; A B Siddique; C Roussilhon; C Rogier; J F Trape; M Troye-Blomberg; K Berzins
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice.

Authors:  Akram Abouie Mehrizi; Niloufar Rezvani; Sedigheh Zakeri; Atefeh Gholami; Laleh Babaeekhou
Journal:  Med Microbiol Immunol       Date:  2018-02-03       Impact factor: 3.402

Review 10.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.